TIDMHVO

RNS Number : 2784L

hVIVO plc

24 April 2015

For immediate release 2.00pm: 24 April 2015

HVIVO PLC

("hVIVO" or the "Company")

2014 Annual Report and Financial Statements

hVIVO plc (AIM: HVO), the pioneer of human challenge models of disease, is pleased to announce that its Annual Report and Financial Statements for the year ended 31 December 2014 is being posted to shareholders today. It will be available on the Company's website (http://hvivo.com/investors/financial-reports/) from 4.30 pm today.

For further information please contact:

hVIVO plc +44 207 756 1300

Kym Denny (Chief Executive Officer)

Graham Yeatman (Chief Financial & Business Officer)

Media Enquiries +44 203 021 3933 / +44 7854 979 420

Colin Paterson (Director of Marketing, Communication and Public Relations)

Numis Securities Limited +44 207 260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Michael Burke (Corporate Broking)

Notes to Editors:

hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases. Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSPKQDQDBKDQQB

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Hvivo
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Hvivo